Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06009159 · ClinicalTrials.gov registry record · NA

Vagus Nerve Stimulation(VNS) As Treatment For Fibromyalgia Patients

A NA study of Fibromyalgia, sponsored by Massachusetts General Hospital.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT06009159 is a NA study of Fibromyalgia that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 60 participants, below the 178-participant average among 76 other Fibromyalgia trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06009159, a NA study of Fibromyalgia, is actively recruiting participants, sponsored by Massachusetts General Hospital.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

Fibromyalgia (FM) is a syndrome with clinical symptoms involving multiple systems. The efficacy of current treatments is inadequate, and more alternative modalities are needed for the management of FM patients. The parasympathetic vagus nerve innervates and integrates sensory, motor, and autonomic systems and has been suggested to play a role in pain modulation. The role of vagus nerve stimulation (VNS) as a treatment option for FM patients is yet to be investigated. The investigators propose to examine the hypothesis that vagus nerve stimulation could improve pain and related comorbid symptoms for FM patients.

Conditions Studied

Interventions

  • DEVICE Transcutaneous Vagus Nerve Stimulation

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2024-07-01
Est. Completion 2026-10-31
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT06009159

The ClinicalTrials.gov registry entry for NCT06009159 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 178-participant average among 76 other Fibromyalgia trials with a reported enrollment target (66% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Fibromyalgia appearing as the primary indexed condition, and to 1 intervention - of which Transcutaneous Vagus Nerve Stimulation is the first listed.

NCT06009159 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06009159 about?

NCT06009159 is a clinical study titled "Vagus Nerve Stimulation(VNS) As Treatment For Fibromyalgia Patients". Fibromyalgia (FM) is a syndrome with clinical symptoms involving multiple systems. The efficacy of current treatments is inadequate, and more alternative modalities are needed for the management of FM patients. The parasympathetic vagus nerve innervates and integrates sensory, motor, and autonomic s...

What is the current status of trial NCT06009159?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2024-07-01. Estimated completion is 2026-10-31.

What conditions does trial NCT06009159 study?

This clinical trial studies the following conditions: Fibromyalgia.

What interventions are being tested in trial NCT06009159?

The interventions under investigation include: Transcutaneous Vagus Nerve Stimulation (DEVICE).

Who is sponsoring clinical trial NCT06009159?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06009159 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Fibromyalgia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.